Countries Australia

Biointelect and CR2O Partner to Revolutionize Global Life Science Commercialization

Biointelect and CR2O have announced a strategic partnership aimed at delivering comprehensive commercialization solutions. This collaboration marks a miles...

 February 15, 2024 | News

Biocon Biologics Teams Up with Sandoz Australia for Biosimilar Trastuzumab and Bevacizumab

Under the agreement, Sandoz will distribute the Biocon Biologics' brands, OGIVRI® (bTrastuzumab) and ABEVMY® (bBevacizumab), and facilita...

 February 09, 2024 | News

Aurora Cannabis Expands Global Footprint with Acquisition of MedReleaf Australia

  MedReleaf Australia, holding the coveted #2 spot in the rapidly growing Australian medical cannabis market, was acquired by Aurora in a transaction...

 February 09, 2024 | News

Telix to Acquire QSAM Biosciences, Bolstering Bone Cancer Targeting

  153Sm-DOTMP utilizes a cutting-edge chelating agent to deliver Samarium-153 radioisotope, offering potential advancements in bone cancer treatment....

 February 08, 2024 | News

ShiraTronics finishes Australian pilot study enrollment, gears up for pivotal clinical trial

Migraine, recognized globally as a significant cause of disability, particularly among pre-menopausal women, poses a substantial health challenge. For arou...

 February 07, 2024 | News

Stakeholders Rally for Sustainable Funding to Secure Australia's Future of National One Stop Shop for Clinical Trials

The NOSS, a pioneering digital platform, seeks to streamline the approval and reporting procedures for human research, particularly clinical trials, in Aus...

 February 06, 2024 | News

Sirius Therapeutics Begins Phase 1 Trial for Long-Acting Factor XI siRNA Anticoagulant

"This study is based on in vivo studies that have demonstrated a nearly 100% reduction in FXI levels for up to 6 months without bleeding events a...

 February 04, 2024 | News

Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study

 Endogenex, Inc., a clinical stage medical device company dedicated to improving outcomes in patients with Type 2 Diabetes (T2D), announced that the U...

 January 31, 2024 | News

Australia's Island Pharma Advances ISLA-101 Study: Third Cohort Successfully Dosed

This achievement follows the recent confirmation from the Data Safety Review Committee that ISLA-101 has been deemed safe and well-tolerated in the 16 subj...

 January 23, 2024 | News

Life Sciences Queensland Welcomes Dr. Kym Baker and Dr. Denise Hodge to Board Leadership

Dr. Kym Baker, currently serving as the General Manager of Patheon Biologics at Thermo Fisher Scientific Brisbane Biologics site, brings over 30 years of e...

 January 23, 2024 | News

CSIRO Invites Australian SMEs to Join Innovate to Grow Program for Advancing Digital Health and Medical Tech

Australia’s CSIRO is actively seeking startups and small to medium-sized enterprises (SMEs) eager to drive innovation in digital health and medical t...

 January 23, 2024 | News

TGA Grants Approval to Australia's Pioneering RSV Vaccine, AREXVY

AREXVY has been approved by the Therapeutic Goods Administration (TGA) for Australians 60 and over to protect against lower airway infection caused by re...

 January 19, 2024 | Regulatory

Immunexpress' SeptiCyte RAPID® Gains TGA Clearance in Australia

Immunexpress, a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced that SeptiCyte® RAPID has rec...

 January 17, 2024 | News

Smith+Nephew Report Urges Overhaul of Musculoskeletal Injury Care and Reimbursement in Australia

  The Economist Impact - Musculoskeletal Injuries in Australia Report outlines the growing number of meniscal injury (MI) and rotator cuff (RC) injur...

 January 15, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close